The National Association of Boards of Pharmacy (NABP) agreed to a $845,800 settlement to resolve claims that it incorrectly “failed” NAPLEX test takers despite them passing the exams.
Plaintiffs in the class action lawsuit claim that NABP negligently misscored hundreds of NAPLEX tests, resulting in candidates receiving a false “fail” result. This allegedly happened once in 2021 and then again only a year later.
The National Association of Boards of Pharmacy is a nonprofit that helps access pharmacist competency, facilitate licensure transfers and verifications and other professional services.
NABP hasn’t admitted any wrongdoing but agreed to pay $845,800 to resolve the NAPLEX test class action lawsuit.
NABP NAPLEX Test Class Action Lawsuit
- Who’s Eligible:
- 2021 class: candidates who took the NAPLEX test administered by the National Association of Boards of Pharmacy between Aug. 31 and Sept. 8, 2021, who received a Sept. 17, 2021, notice that their NAPLEX score was incorrectly reported as “failed” when they had actually passed the test.
- 2022 class: candidates who took the NAPLEX test administered by the NABP between July 30 and Oct. 26, 2022, who received a Nov. 8, 2021, notice that their NAPLEX score was incorrectly reported.
- Estimated Amount: $7,500
- Proof of Purchase: NABP e-Profile ID number
- Claim Form Deadline: 01/12/2024
- Case Name & Number:
- Glaspie v. National Association of Boards of Pharmacy, Case No. 1:22-cv-06497, in the U.S. District Court for the Northern District of Illinois
- How to file a claim:
- Head over to the Claim Form.
- Read over the claim form to see if you are eligible.
- Complete the claim form with your info.
- Submit your claim form to receive your potential award!
(Click here to file a claim)
 |
Bottom Line
Don’t forget to take a look at our full list of Class Action Lawsuit Settlements! Be sure to give our list of No-Proof Class Action lawsuit to see other settlements you may qualify for.
The post NABP NAPLEX Test Class Action Lawsuit appeared first on Hustler Money Blog.